Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-044859

President, R&D sold 8,000 shares at $20.00 ($160,000)

  • President, R&D acquired 8,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bergstrom Donald A President, R&D 2022-08-05 Option exercise +8,000 $4.12 $32,960 97,659 D
Bergstrom Donald A President, R&D 2022-08-05 Sale −8,000 $20.00 $160,000 89,659 D
Derivatives
Bergstrom Donald A President, R&D 2022-08-05 Option exercise · Stock Option (Right to Buy) −8,000 162,456 D
Open-market sales · 8,000 sh · avg $20.00 · $160,000
Loading xslF345X03/doc4.xml…